Hamid Pouraliakbar

Prof. Dr. Hamid Pouraliakbar

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 December 2021 in European Heart Journal - Cardiovascular Pharmacotherapy
Verified
Journal Article
Closed access
PDF file
PSParham Sadeghipour
Parham Sadeghipour
SSSedigheh Saedi
Sedigheh Saedi
LSLeila Saneei
Leila Saneei
FRFarnaz Rafiee
Farnaz Rafiee
SYSiamak Yoosefi
Siamak Yoosefi
Raffaele De CaterinaRaffaele De Caterina
Raffaele De Caterina
Thrombolysis is an alternative to surgery for mechanical prosthetic valve thrombosis (MPVT). Randomized clinical trials have yet to test safety and efficacy of a proposed ultraslow thrombolytic infusion regimen. This single-center, open-label, pilot randomized clinical trial randomized adult patients with acute obstructive MPVT to an ultraslow thrombolytic regimen (25 mg of recombinant tissue-type plasminogen activator [rtPA] infused in 25h) and a fast thrombolytic regimen (50 mg of rtPA infused in 6h). If thrombolysis failed, a repeated dose of 25 mg of rtPA for 6h was administered in both groups up to a cumulative dose of 150 mg or the occurrence of a complication. Primary outcome was a complete MPVT resolution (>75% fall in the obstructive gradient by transthoracic echocardiography, <10° limitation in opening and closing valve motion angles by fluoroscopy, and symptom improvement). Key safety outcome was a BARC type III or V major bleeding. Overall, 120 patients, including 63 (52.5%) women, at a mean age of 36.3±15.3 years, were randomized. Complete thrombolysis success was achieved in 51 patients (85.0%) in the ultraslow-regimen group and 47 patients (78.3%) in the fast-regimen group (OR, 1.58; 95% CI, 0.25 to 1.63; P = 0.34). One case of transient ischemic attack and 3 cases of intracranial hemorrhage (absolute risk difference, −12.5%; 95% CI, −23.1% to −1.0%; P = 0.04). were observed only in the fast-regimen group. The ultraslow thrombolytic regimen conferred a high thrombosis resolution rate without major complications. Such findings should be replicated in more adequately powered trials (IRCT20181022041406N2).

14 January 2021 in ESC Heart Failure
Verified
Journal Article
Open access
PDF file
MCMitra Chitsazan
Mitra Chitsazan
AAAhmad Amin
Ahmad Amin
MCMandana Chitsazan
Mandana Chitsazan
NZnaghmeh ziaei
naghmeh ziaei
PMParviz Amri Maleh
Parviz Amri Maleh
Stephan Von HaehlingStephan Von Haehling
Stephan Von Haehling
The impact of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) on diastolic function is less known. We describe a 46‐year‐old man with a history of mild hypertension who presented to the emergency department with fever, cough, and myalgia for 2 days. The patient was tested positive for SARS‐CoV‐2. He was admitted and started on a combination of antiviral and antimicrobial therapy. He developed respiratory distress 2 days later, and O2 saturation declined. Blood tests showed an increased N‐terminal pro‐B type natriuretic peptide (NT‐proBNP) level, and echocardiography showed normal left ventricular ejection fraction and E/e′ ratio of 16. Computed tomography scan showed interstitial pulmonary oedema and prominent peripheral pulmonary vascular markings. Given these findings, heart failure with preserved ejection fraction (HFpEF) was considered. Low‐dose diuretic was started, and fluid administration was restricted, resulting in a decrease in NT‐proBNP level, clinical and haemodynamic stabilization, and improved oxygenation. This case highlights the occurrence of HFpEF in coronavirus disease 2019.

16 May 2023 in Heart Failure Reviews
Verified
Journal Article
Closed access
PDF file
PPParmida Sadat Pezeshki
Parmida Sadat Pezeshki
SGSeyyed Mojtaba Ghorashi
Seyyed Mojtaba Ghorashi
GHGolnaz Houshmand
Golnaz Houshmand
MGMojdeh Ganjparvar
Mojdeh Ganjparvar
HPHamid Pouraliakbar
Hamid Pouraliakbar
NONegar Omidi
Negar Omidi

2 July 2024 in Biomechanics and Modeling in Mechanobiology
Verified
Journal Article
Closed access
PDF file
Saeed TorbatiSaeed Torbati
Saeed Torbati
ADAlireza Daneshmehr
Alireza Daneshmehr
HPHamid Pouraliakbar
Hamid Pouraliakbar
MAMasoud Asgharian
Masoud Asgharian
STSeyed Hossein Ahmadi Tafti
Seyed Hossein Ahmadi Tafti
AHAlireza Heidari
Alireza Heidari

1 March 2020 in Cardiovascular Pathology
Verified
Journal Article
Closed access
LPLeili Pourafkari
Leili Pourafkari
ASAnita Sadeghpour
Anita Sadeghpour
Aidin BaghbaniAidin Baghbani
Aidin Baghbani
SSSafa Savadi-Oskouei
Safa Savadi-Oskouei
HPHamid Pouraliakbar
Hamid Pouraliakbar
NNNader Nader
Nader Nader

28 September 2025 in Bioengineering
Verified
Journal Article
Open access
PDF file
Nima RahmatiNima Rahmati
Nima Rahmati
HPHamid Pouraliakbar
Hamid Pouraliakbar
AEArshia Eskandari
Arshia Eskandari
KJKian Javari
Kian Javari
AJAlireza Jabbarinick
Alireza Jabbarinick
MAMona Alimohammadi
Mona Alimohammadi
The common iliac artery supplies blood to the lower extremities, and stenosis in this region severely impacts hemodynamics. This study investigates the effects of 25%, 50%, and 75% iliac artery stenosis on key hemodynamic parameters using a fluid–structure interaction (FSI) approach. Semi-idealized geometries reconstructed from patient-specific data modeled realistic arterial behavior. Parameters such as wall displacement, time-averaged wall shear stress (TAWSS), oscillatory shear index (OSI), high oscillatory low shear magnitude (HOLMES) index, and endothelial cell activation potential (ECAP) were evaluated. Results showed peak wall displacement of 2.85 mm in the bifurcation zone under 75% stenosis. TAWSS increased with stenosis severity, peaking in stenotic regions and decreasing significantly downstream. OSI was highest in non-stenosed right branches and bifurcation areas, indicating multidirectional shear forces. HOLMES values were lowest downstream of stenoses, indicating disturbed flow. ECAP exceeded the thrombosis risk threshold (1.4 Pa−1) in post-stenotic zones under 75% stenosis, suggesting a higher risk of clot formation. These results demonstrate that stenosis disrupts local flow and causes hemodynamic changes downstream, emphasizing the need for comprehensive clinical assessment beyond the stenotic site. Regions with elevated ECAP and low HOLMES downstream may be prone to thrombosis, highlighting the importance of careful hemodynamic monitoring for treatment strategies.